Catapult Semi-Finals

EIT Health Catapult provides investors and industry representatives an excellent opportunity to gain access to a concentrated elite group of top European start-up companies keen to collaborate with strong partners, when they take their first steps towards economic value creation. We would like to invite investors and industry representatives to our semifinals, in which top start-up companies from all over Europe are pitching in front of a hand-picked jury consisting of healthcare professionals with various fields of expertise after 2 days of intense mentoring and business model optimization.  


Pitching on 21 October 2020

Pitching on 22 October 2020

Pitching on 23 October 2020

Our Semi-Finalists

Discover our 42 semifinalists that will pitch in front of a jury and audience of market experts and investors. We have gathered together some of the most highly respected professionals in the industry to participate in this special event.


Speakers are listed in order of appearance in the agenda.


EIT Health Catapult partners with leading healthcare players to award the semi-finalists for their success so far, and to support their future growth. A big thank you to all of our sponsors and contributors who have provided the wonderful prizes for the 2020 semi-finalists. Join the pitch days' Awards Ceremonies to find out who will be crowned the winning start-ups!


About EIT Health Catapult Programme

Every year the programme sources and accelerates 42 European start-ups in biotech, medtech and digital health that get high-quality training in business modelling and planning, investment deal negotiation and pitch training, as well as a facilitated access to top level experts and investors.

Catapult start-ups are fast-tracked to becoming part of the EIT Health Community of world leading medtech, biotech, pharma and IT companies and international class research organizations in health care as well as the EIT Health Investors Network that unites international investors (VCs, Corporate VCs, Business Angel, and Crowd Investors).